- Published on
Emergency and Acute Medicine – Necrotizing Soft Tissue Infections
Necrotizing soft tissue infections (NSTIs) are rapidly progressive infections involving any layer of the skin and underlying soft tissues, characterized by widespread necrosis, severe systemic toxicity, and a high mortality rate. These infections spread quickly along tissue planes, often causing extensive fascial and muscle destruction with relative sparing of the skin in early stages. Clinical entities within this spectrum include necrotizing fasciitis, Fournier gangrene, clostridial and nonclostridial myonecrosis, crepitant anaerobic cellulitis, and progressive bacterial gangrene. Despite being uncommon, NSTIs carry mortality rates of 24–34% and are associated with significant morbidity such as amputations, renal failure, and prolonged critical illness.
NSTIs typically arise in the setting of local tissue trauma, ischemia, or impaired host defenses. Risk is increased in older adults, smokers, and patients with chronic systemic disease including diabetes mellitus, obesity, peripheral vascular disease, chronic kidney disease, alcohol abuse, immunosuppression, and intravenous drug use. Type I NSTIs, which account for approximately 80% of cases, are polymicrobial infections involving aerobic and anaerobic organisms and commonly occur after surgery or in patients with chronic illness. Type II NSTIs are usually monomicrobial, most often caused by group A β-hemolytic streptococcus, and can affect young, otherwise healthy individuals; these infections are the classic “flesh-eating” disease. Type III NSTIs are rare but fulminant, frequently clostridial in origin, and often follow penetrating trauma, crush injuries, or injection drug use. Pediatric cases are uncommon but may occur in neonates after omphalitis or circumcision, or in children following recent varicella infection, surgery, or in those with immunodeficiency.
The clinical presentation can be subtle early but deteriorates rapidly. Patients often report fever, malaise, altered mental status, and severe pain at the affected site. A hallmark feature is pain that is disproportionate to physical findings. Within the first 24 hours, localized swelling, warmth, erythema, and tenderness develop, followed over the next 24–48 hours by skin discoloration (purple or blue), hemorrhagic bullae, and foul-smelling, thin drainage due to necrosis of fascia and fat. Systemic toxicity is common and includes tachycardia, tachypnea, hypotension, fever, and mental status changes. Crepitus, while pathognomonic, is present in only a minority of cases. In children, localized pain and rash are the most common presenting features, while hypotension and shock are less frequent early findings.
Diagnosis is challenging and relies heavily on clinical suspicion, particularly in high-risk patients who appear severely ill or have pain out of proportion to examination findings. Laboratory abnormalities may include leukocytosis, electrolyte derangements, renal dysfunction, hypocalcemia from fat necrosis, and evidence of disseminated intravascular coagulation. Imaging studies such as plain radiographs, CT, MRI, or ultrasound may demonstrate soft tissue gas, fascial thickening, or fluid along fascial planes, but absence of these findings does not exclude NSTI. Importantly, imaging should never delay surgical intervention. Definitive diagnosis is established by surgical exploration with deep tissue biopsy and cultures, which remains the gold standard.
Management of NSTIs is a true surgical emergency. Initial stabilization focuses on airway protection, aggressive fluid resuscitation, oxygenation, and correction of metabolic disturbances. Broad-spectrum intravenous antibiotics must be initiated immediately, targeting aerobic gram-positive and gram-negative organisms, anaerobes, and methicillin-resistant Staphylococcus aureus until culture results are available. Clindamycin should be started early, particularly when group A streptococcal infection is suspected, due to its ability to suppress toxin production. However, antimicrobial therapy alone is insufficient; early and aggressive surgical debridement of all necrotic tissue with fasciotomy and drainage is the cornerstone of treatment and must not be delayed. Adjunctive therapies such as hyperbaric oxygen and intravenous immunoglobulin may be considered in select cases, though their roles remain controversial.
All patients with NSTI require hospital admission, typically to an intensive care setting, for ongoing surgical management, intravenous antibiotics, and close monitoring for complications such as acute respiratory distress syndrome, renal failure, myocardial dysfunction, and disseminated intravascular coagulation. No patient with NSTI is appropriate for discharge. Key clinical pearls include maintaining a high index of suspicion, recognizing pain out of proportion to examination as a critical clue, and understanding that mortality approaches 100% if treatment is limited to antibiotics without prompt surgical debridement.
- Published on
KembaraXtra-Emergency and Acute Medicine - Osgood–Schlatter Disease
Description: Osgood–Schlatter disease is the most common cause of knee pain in children aged 10–15 years and represents a benign, self-limited extra-articular condition. It is characterized by pain, swelling, and tenderness over the tibial tuberosity at the insertion of the patellar tendon, just below the knee joint. Symptoms are activity related, worsening with exercise and improving with rest, and are commonly seen in physically active adolescents during periods of rapid growth.
Etiology: The most widely accepted mechanism involves repetitive traction and microfractures at the tibial tubercle apophysis caused by repeated stress from the patellar tendon. Activities that involve running, jumping, and sudden changes in direction increase strain on the extensor mechanism and precipitate symptoms.
Clinical features: Patients present with localized pain and swelling over the tibial tuberosity that is exacerbated by running, jumping, kneeling, or climbing stairs and relieved by rest. The condition is usually unilateral, although bilateral involvement occurs in approximately 20% of cases. Risk factors include age between 10 and 15 years, male sex, pubertal growth spurts, and participation in sports such as soccer, basketball, volleyball, and skating.
Physical examination: Examination reveals prominence, tenderness, and soft tissue swelling over the tibial tuberosity with pain reproduced by resisted knee extension. Quadriceps and hamstring tightness is common compared with the unaffected side. Mild erythema may be present, but the knee joint examination itself is otherwise normal, with no effusion or instability.
Evaluation: Diagnosis is primarily clinical based on history and examination. Imaging is not routinely required but may be obtained if the diagnosis is uncertain or to exclude other pathology. Plain knee radiographs may show fragmentation or irregular ossification of the tibial tuberosity, while ultrasound can demonstrate associated soft tissue changes.
Management: Treatment is conservative and focuses on symptom control and activity modification. Patients should rest from painful activities for approximately 6–8 weeks, particularly avoiding jumping and cutting sports. Ice application, stretching of the quadriceps and hamstrings, and use of analgesics such as ibuprofen or acetaminophen are recommended. An infrapatellar tendon strap or protective padding may reduce strain during activities. Corticosteroid injections should be avoided, and reassurance is essential as the condition resolves with skeletal maturity.
Disposition and follow-up: Admission is not required, and patients can be safely discharged home. Follow-up with a pediatrician or primary care provider in 2–3 weeks is advised to reassess symptoms and activity tolerance. Referral to pediatric orthopedics is rarely necessary and is reserved for patients
- Published on
KembaraXtra-Emergency and Acute Medicine - Opiate Poisoning
Description: Opiates bind to μ, κ, and δ receptors in the central and peripheral nervous systems, producing analgesia, sedation, and respiratory depression. Both physical and psychological dependence can develop. Peak plasma levels occur within 1–2 hours after oral ingestion, 30–60 minutes after intramuscular use, and seconds to minutes after intravenous or intranasal exposure.
Etiology: Opiate poisoning most commonly results from overuse or abuse of prescription analgesics used for moderate to severe pain. Street preparations may be adulterated with substances such as cocaine, clenbuterol, phencyclidine, strychnine, dextromethorphan, quinine, or scopolamine, which can alter clinical presentation and severity.
Clinical features: Central nervous system effects include somnolence, CNS depression, coma, and seizures. Respiratory depression, apnea, bronchospasm, and noncardiogenic pulmonary edema may occur. Cardiovascular manifestations include hypotension, bradycardia, and palpitations. Gastrointestinal findings include nausea, vomiting, and constipation. Other classic features include miosis and hypothermia. Withdrawal presents with hypertension, tachycardia, tachypnea, abdominal cramps, diarrhea, piloerection, yawning, and agitation. Neonates exposed in utero may develop withdrawal within 12–72 hours after birth, presenting with irritability, tremors, poor feeding, and dehydration. Diphenoxylate toxicity is particularly dangerous in children and may be fatal.
Evaluation: Continuous monitoring of vital signs and respiratory status is essential in significant exposures. Pulse oximetry or arterial blood gases should be obtained, with chest radiography performed for persistent hypoxia, pulmonary edema, or aspiration. Abdominal radiographs are indicated if body packing is suspected. A thorough physical examination should include inspection for occult opioid patches such as fentanyl.
Diagnostic testing: Plasma opioid levels are not clinically useful and treatment is guided by presentation. Urine toxicology screens may fail to detect synthetic opioids such as methadone. An acetaminophen level must be obtained in all suspected oral opioid overdoses due to frequent coformulation and risk of occult toxicity.
Management: Initial management prioritizes airway protection, oxygen supplementation, and circulatory support. Naloxone should be administered promptly to reverse respiratory depression and coma, with cautious low-dose titration in opioid-dependent patients to avoid severe withdrawal. Repeated dosing or continuous infusion may be required for long-acting opioids such as methadone or fentanyl. Endotracheal intubation is indicated if respiratory depression persists despite naloxone. Activated charcoal may be given for recent oral ingestion if the airway is protected. Whole-bowel irrigation with polyethylene glycol is recommended for asymptomatic body packers. Hypotension is treated with intravenous fluids and vasopressors if refractory. Seizures are treated initially with benzodiazepines, followed by phenobarbital if needed. Opioid withdrawal may be managed with clonidine or methadone.
Disposition and follow-up: Admission is required for patients with persistent symptoms, need for repeated naloxone dosing or infusion, body packers, young children after diphenoxylate ingestion, or suspected coingestants. Patients may be discharged if asymptomatic after appropriate observation—6 hours after oral overdose or 4 hours after naloxone administration—and after confirmed elimination of opioid packets when applicable. All patients should receive substance abuse referral, poison prevention counseling for accidental exposures, and psychiatric evaluation for intentional ingestions.
Pearls and pitfalls: Always consider occult acetaminophen poisoning in chronic opioid users. Synthetic and semisynthetic opioids may not appear on standard urine drug screens. Buprenorphine can cause prolonged sedation in children. Used opioid patches still contain clinically significant drug amounts and may cause severe toxicity.
- Published on
KembaraXtra-Emergency and Acute Medicine - Opportunistic Infections
Description: Opportunistic infections are unusual infections that occur when host defenses are impaired, allowing normally nonpathogenic organisms to cause disease. They are most commonly associated with advanced immunosuppression and may present with subtle or atypical signs, yet progress rapidly to severe systemic illness.
Etiology: In patients with HIV/AIDS, opportunistic infections typically occur when the CD4 T-lymphocyte count falls below 200 cells/mm³ or <14% of total lymphocytes. common pathogens include pneumocystis jiroveci (pcp), disseminated tuberculosis, toxoplasma gondii, cryptococcus, histoplasma, cytomegalovirus, mycobacterium avium complex, jc virus (progressive multifocal leukoencephalopathy), hepatitis b virus, and human herpesvirus-8 (kaposi sarcoma). cell-mediated immune deficiency from hematologic malignancies, lymphoma, high-dose glucocorticoids, autoimmune disease, chemotherapy, radiation, or viral infections predisposes to such as legionella, nocardia, salmonella, mycobacteria. neutrophil impairment depletion due cytotoxic drugs, aplastic anemia, marrow infiltration, drug reactions, vitamin deficiencies increases risk for with staphylococcus, α-hemolytic streptococcus, enteric organisms, anaerobes, invasive aspergillosis.< />pan>
Clinical features: Patients may present with new or worsening fatigue, fever or hypothermia, chills, night sweats, tachypnea, and signs of systemic inflammatory response. Pulmonary sources cause cough, dyspnea, and rales; genitourinary sources cause dysuria, frequency, or retention; gastrointestinal sources cause abdominal pain, vomiting, diarrhea, bleeding, or jaundice; and CNS involvement may cause confusion, headache, focal neurologic deficits, or seizures. Ambulatory hypoxia is characteristic of PCP pneumonia, and oropharyngeal candidiasis is a key marker of immune suppression.
Evaluation: A thorough history is essential, including known HIV status and CD4 count, malignancy or transplant history, autoimmune disease, and use of cytotoxic or high-dose steroid therapy. Physical examination must be comprehensive, as classic signs of infection may be minimal or absent. Fever or any clinical deterioration should prompt full evaluation.
Diagnostic testing: Laboratory evaluation includes CBC with differential to identify leukocytosis or neutropenia, calculation of absolute neutrophil count, blood and site-specific cultures, urinalysis, electrolytes, renal function, glucose, lactate, coagulation studies, and LDH (often elevated in PCP). If CD4 count is unknown, an absolute lymphocyte count <1,000 />mu;L predicts CD4 <200. imaging includes chest radiography, which may show nonspecific infiltrates or bilateral interstitial changes in pcp, and high-resolution ct of the for early pcp detection. head with contrast is indicated focal neurologic deficits suspected toxoplasmosis, abdominal pelvic warranted when a gastrointestinal source suspected. lumbar puncture required cns infection suspected, diagnostic paracentesis should be performed immunocompromised patients ascites.< />pan>
Management: Initial stabilization focuses on airway, breathing, and circulation, with supplemental oxygen, IV access, fluid resuscitation for hypotension, cardiac monitoring, and early empiric antimicrobial therapy. Broad-spectrum antibiotics are initiated promptly, often using antipseudomonal penicillins with aminoglycosides or monotherapy with third- or fourth-generation cephalosporins, fluoroquinolones, or carbapenems when indicated. Vancomycin is added in areas with high prevalence of resistant organisms. Antifungal therapy is initiated if there is no improvement after adequate antibacterial coverage, and trimethoprim–sulfamethoxazole is first-line therapy for suspected PCP, with alternatives for intolerance. Corticosteroids are indicated in PCP with hypoxemia and should be started within 72 hours of antimicrobial therapy.
Disposition and follow-up: All patients with suspected or confirmed systemic opportunistic infections require hospital admission. Discharge is appropriate only when systemic infection has been confidently excluded. Infectious disease consultation is strongly recommended. Clinicians must maintain a high index of suspicion, as immunocompromised patients may present with minimal signs yet deteriorate rapidly.
- Published on
KembaraXtra-Emergency and Acute Medicine - Optic Neuritis
Description: Optic neuritis is an inflammatory disorder of the optic nerve resulting in demyelination and acute optic nerve dysfunction. It is strongly associated with multiple sclerosis and is the presenting manifestation in approximately 15–20% of patients with MS. Inflammation may involve the optic disc (papillitis) or the retrobulbar portion of the optic nerve, where the funduscopic examination may initially appear normal. The long-term risk of developing clinically definite MS depends on MRI findings, with significantly higher risk in patients demonstrating multiple demyelinating lesions.
Etiology and risk factors: Most cases are idiopathic and self-limited, but 20–50% are associated with multiple sclerosis. Other causes include postviral inflammation following infections such as varicella, measles, mononucleosis, HSV, or VZV, typically occurring weeks after illness. Granulomatous and infectious causes include tuberculosis, syphilis, sarcoidosis, cryptococcosis, Lyme disease, and HIV-related infections. Drug-induced optic neuritis has been reported with amiodarone, ethambutol, and tamoxifen. Genetic predisposition is suggested by associations with HLA-A23, B7, and DR2 alleles.
Clinical features: Patients typically present with subacute vision loss developing over days, peaking within 1–2 weeks, most often unilateral in adults and bilateral in children. Retrobulbar pain, worsened by eye movement, is characteristic. Color vision, contrast sensitivity, and depth perception are disproportionately affected compared with visual acuity. An afferent pupillary defect is common in unilateral cases. Visual field testing often reveals a central scotoma. Funduscopic examination may show optic disc swelling or appear normal. Uhthoff phenomenon, transient worsening of vision with heat or exertion, may occur.
Evaluation: A detailed history should assess age, sex, onset and progression of visual loss, eye pain, prior neurologic symptoms, recent infections, drug exposure, and family history of MS. Physical examination requires a complete ophthalmologic and neurologic assessment including visual acuity, pupillary reflexes, color vision testing, visual fields, and dilated fundus examination. Blood pressure should be assessed to exclude hypertensive optic neuropathy.
Diagnostic testing: MRI of the brain and orbits with gadolinium is the imaging modality of choice and demonstrates optic nerve enhancement in the majority of acute cases while also stratifying future MS risk. CT is less sensitive and primarily used to exclude compressive lesions. Laboratory evaluation is guided by clinical suspicion and may include CBC, ESR, syphilis serology, Lyme testing, ANA, HIV testing, and tuberculosis screening. Chest radiography may assist in evaluating sarcoidosis or tuberculosis. Formal automated visual field testing is recommended for baseline assessment and follow-up.
Management: Early ophthalmology and neurology consultation is essential. High-dose IV corticosteroids followed by an oral taper are recommended for patients with severe visual loss or those with two or more demyelinating lesions on MRI, as this shortens recovery time and reduces short-term risk of MS progression. Oral corticosteroids alone should be avoided, as they increase recurrence risk. Treatment decisions should be individualized in patients with fewer MRI lesions.
Disposition and follow-up: Admission is indicated for bilateral vision loss, diagnostic uncertainty, or when IV steroid therapy is required. Patients with unilateral involvement, stable condition, and reliable follow-up may be discharged with urgent neurology and ophthalmology review. High-risk patients should be referred for disease-modifying therapy consideration. Prompt follow-up is mandatory, as MRI findings are the strongest predictor of future multiple sclerosis.
Key points: Space-occupying lesions must be excluded before diagnosing optic neuritis. Acute bilateral visual loss with headache or diplopia raises concern for alternative emergencies such as pituitary apoplexy. MRI is critical for prognostication, and management should be coordinated with specialists to align with current standards of care.
- Published on
KembaraXtra-Emergency and Acute Medicine - Organophosphate Poisoning
Description: Organophosphate poisoning results from irreversible inhibition of cholinesterase enzymes, particularly acetylcholinesterase, leading to accumulation of acetylcholine at central and peripheral synapses and subsequent cholinergic overdrive. Toxic effects involve muscarinic, nicotinic, and central nervous system pathways, which may overlap in presentation. Mortality is primarily due to respiratory failure caused by bronchorrhea, bronchoconstriction, respiratory muscle weakness, and central respiratory depression. In children, symptoms may be difficult to distinguish, and seizures occur more frequently than in adults.
Etiology: Exposure commonly occurs through agricultural insecticides or chemical nerve agents such as sarin, soman, tabun, and VX. These agents are rapidly absorbed through the lungs, gastrointestinal tract, skin, mucous membranes, and eyes, making even dermal exposure potentially life-threatening.
Clinical features: The classic presentation is the cholinergic toxidrome characterized by DUMBELS: diarrhea and diaphoresis, urination, miosis and muscle fasciculations, bradycardia with bronchorrhea and bronchospasm, emesis, lacrimation, and salivation. Mild exposure causes headache, dizziness, weakness, tremors, and anorexia. Moderate exposure leads to muscle fasciculations progressing to flaccid paralysis, respiratory muscle weakness, agitation, confusion, pinpoint pupils, nausea, vomiting, and excessive secretions. Severe exposure presents with seizures, coma, centrally mediated respiratory depression, bronchoconstriction, cyanosis, cardiac conduction abnormalities, profuse secretions, and urinary or fecal incontinence.
Evaluation: A focused history should assess occupational exposure, recent insecticide use, possible suicide attempt, and access to pesticides, with retrieval of the original container if available. Physical examination emphasizes identification of parasympathetic signs, muscle weakness, and respiratory compromise. Diagnosis is clinical, and treatment should not be delayed for laboratory confirmation.
Diagnostic testing: Red blood cell cholinesterase levels best reflect synaptic inhibition but are often delayed, while plasma cholinesterase levels are more rapidly available but less specific. Severity correlates with the degree of enzyme inhibition, though therapy must begin immediately regardless of results. Additional testing includes CBC, electrolytes, renal function, glucose, arterial blood gas when respiratory symptoms are present, ECG for dysrhythmias or heart block, and chest radiography if pulmonary edema or aspiration is suspected.
Management: Initial management prioritizes decontamination and protection of healthcare workers using appropriate personal protective equipment. All contaminated clothing should be removed and double-bagged, and skin thoroughly washed with soap and water. Airway protection, oxygenation, and ventilatory support are critical, with early intubation when indicated. Atropine is the primary antidote for muscarinic symptoms and should be administered in escalating doses every five minutes until bronchial secretions are dry, without using pupil size or heart rate as treatment endpoints. Pralidoxime should be given early to reverse nicotinic effects and regenerate cholinesterase before enzyme aging occurs, improving muscle strength and reducing paralysis. Supportive care includes frequent suctioning, avoidance of succinylcholine during intubation, and cautious gastric decontamination in early severe ingestions.
Disposition and follow-up: Any symptomatic patient or those requiring atropine should be admitted, typically to an intensive care setting, for close monitoring. Asymptomatic patients may be discharged after 6–12 hours of observation with clear return precautions and reliable follow-up. Intentional exposures require psychiatric evaluation, and poison control or toxicology consultation is recommended for significant or ongoing symptoms.
Key points: Inadequate atropine dosing is the most common cause of treatment failure. Clinical diagnosis should guide therapy without delay for laboratory confirmation. Recognition and aggressive management of respiratory compromise are essential to reduce mortality.
- Published on
KembaraXtra-Emergency and Acute Medicine - Osteomyelitis
Description: Osteomyelitis is an infection of bone characterized by ongoing inflammatory destruction. It is most commonly bacterial in origin, although fungal osteomyelitis can occur, particularly in immunocompromised patients. The disease may present as acute, subacute, or chronic infection, with chronic cases defined by persistence or recurrence and the presence of necrotic bone (sequestrum).
Etiology: Hematogenous osteomyelitis occurs when bacteria seed bone via the bloodstream and is most common in children, the elderly, and people who inject drugs. Children typically develop acute disease, often without a preceding illness, though up to one-third report recent trauma. Adults more often develop subacute or chronic disease. Staphylococcus aureus is the most common pathogen across all age groups. Neonates are additionally affected by Enterobacteriaceae, group A and B streptococci, and Escherichia coli. Children may also develop infection from Haemophilus influenzae, while Salmonella is classically associated with sickle cell disease. Adults may have infections caused by gram-negative rods, Pseudomonas, Staphylococcus epidermidis, and anaerobes. Vertebral osteomyelitis is uncommon but typically affects adults over 45 years, often in the setting of diabetes, malignancy, hemodialysis, long-term catheterization, or IV drug use, and may extend to cause epidural abscesses or deep paraspinal collections. Direct or contiguous osteomyelitis occurs following trauma, open fractures, surgery, or spread from adjacent soft tissue infection and is more common in adults and adolescents. Chronic osteomyelitis is associated with necrotic bone and commonly involves S. aureus, S. epidermidis, Pseudomonas aeruginosa, and gram-negative organisms.
Clinical features: Symptoms vary with disease duration. Patients often present with localized, deep, dull, or throbbing bone pain that may occur at rest or with movement. Fever and chills may be present in acute disease but are often absent in chronic infection. Other features include malaise, nausea, vomiting, reluctance to use an affected limb, nonhealing ulcers, or fracture nonunion. Risk factors include diabetes mellitus, vascular disease, IV drug use, trauma, and invasive procedures. Examination may reveal localized warmth, erythema, edema, tenderness, decreased range of motion, sinus tract drainage, or exposed bone. Deep ulcers with palpable bone and a positive “probe-to-bone” test strongly suggest osteomyelitis.
Evaluation: Initial workup includes complete blood count, erythrocyte sedimentation rate, C-reactive protein, plain radiographs, and blood and wound cultures. Leukocytosis may be absent, but inflammatory markers are usually elevated. Blood cultures are positive in approximately half of cases. Plain radiographs are often normal in the first two to three weeks; early findings include periosteal elevation, followed by cortical erosion and new bone formation. MRI is the imaging modality of choice, with high sensitivity and specificity, allowing early detection and assessment of marrow, cortical, and soft tissue involvement. CT is useful when MRI is contraindicated and for surgical planning. Bone scans and leukocyte scintigraphy may be helpful in selected cases, while ultrasound is increasingly useful in children. Definitive diagnosis is established by bone biopsy with histology and culture, which remains the gold standard.
Management: Initial management focuses on stabilization, particularly in septic patients or those with neurologic deficits from spinal involvement. Empiric intravenous antibiotics should be started after cultures are obtained, then tailored based on organism and sensitivities. Treatment typically requires four to six weeks of parenteral antibiotics, with shorter IV courses followed by oral therapy possible in selected pediatric cases. Orthopedic and infectious disease consultation is essential, and surgical intervention is often required for debridement of necrotic bone, infected hardware, or abscesses.
Disposition and follow-up: Patients with acute osteomyelitis should be admitted for intravenous antibiotics and monitoring. Chronic osteomyelitis often requires admission for surgical management and prolonged therapy. Selected subacute or chronic cases may be managed as outpatients if debridement has been performed, cultures obtained, and reliable home IV antibiotic therapy is available. Close follow-up is mandatory to monitor response and prevent recurrence.
Key points: A normal white blood cell count does not exclude osteomyelitis. Early radiographs may be normal, making MRI critical for early diagnosis. Wound cultures alone are often unreliable for guiding therapy, and bone biopsy provides the most accurate microbiologic diagnosis.
- Published on
KembaraXtra -Medicine- Neonatal Sepsis
Neonatal sepsis is a life-threatening systemic infection occurring in newborns, most commonly within the first month of life and rarely up to three months of age. It is predominantly bacterial in origin, with pathogens typically acquired from maternal perineal flora during or around delivery. The incidence is approximately 3–5 cases per 1,000 live births, and despite advances in care, neonatal sepsis remains a major cause of morbidity and mortality. Early recognition is critical because clinical signs are often subtle and rapidly progressive.
The etiology is most commonly bacterial, with Group B Streptococcus, Escherichia coli, and Listeria monocytogenes being the leading pathogens. Other bacterial causes include coagulase-positive and coagulase-negative Staphylococcus species and Treponema pallidum. Viral causes, though less common, include herpes simplex virus, enteroviruses, adenovirus, and cytomegalovirus, while fungal infections such as Candida species are typically seen in premature or immunocompromised infants. Infection may progress to meningitis, which carries a higher risk of long-term neurologic sequelae.
Risk factors are divided into perinatal and neonatal categories. Perinatal risk factors include maternal fever, urinary tract infection, chorioamnionitis, prolonged rupture of membranes exceeding 18 hours, foul lochia, uterine tenderness, and intrapartum asphyxia. Neonatal risk factors include prematurity, fetal tachycardia, male sex, twinning, congenital immune or metabolic disorders such as galactosemia, congenital anomalies, omphalitis, and prior intramuscular iron administration. The presence of any risk factor should significantly lower the threshold for evaluation.
Clinical presentation is often nonspecific. Caregivers may report poor feeding, lethargy, or irritability. On examination, infants may appear toxic with temperature instability, apnea, bradycardia, tachycardia, tachypnea, prolonged capillary refill, mottled or cyanotic skin, abdominal distention, jaundice, or bleeding. Severe disease may progress to septic shock, hypoglycemia, seizures, disseminated intravascular coagulation, cardiovascular collapse, and death if untreated.
Evaluation requires a full sepsis workup followed immediately by empiric antibiotic therapy. Bedside glucose measurement is essential. Laboratory studies include a complete blood count, inflammatory markers such as C-reactive protein, blood cultures, catheterized or suprapubic urine cultures, and cerebrospinal fluid studies when the infant is stable. Additional tests include arterial blood gas analysis, electrolytes, calcium levels, coagulation studies when indicated, and chest radiography to assess for pneumonia.
Management begins with stabilization of airway, breathing, and circulation, including ventilatory support when needed and prompt intravenous access. Empiric antibiotics are initiated immediately, most commonly ampicillin combined with gentamicin or cefotaxime, with vancomycin added if clinical deterioration or resistant organisms are suspected. Supportive care for shock, metabolic derangements, and organ dysfunction is provided as required.
All infants with suspected neonatal sepsis must be admitted for intravenous antibiotics, close monitoring, and supportive care. In practice, any infant younger than one month presenting with fever is generally admitted even if suspicion for sepsis is low. Prognosis depends on the timeliness of treatment, the causative organism, and the presence of complications, emphasizing the importance of early recognition and aggressive management.
- Published on
Emergency and Acute Medicine – Osteoporosis
Osteoporosis is characterized by a diffuse decrease in skeletal mass, with trabecular bone—particularly in the vertebrae and femur—affected earlier and more severely than cortical bone. Although the disease process begins in adolescence, fractures typically do not manifest until age 50 years or older. Females are affected far more commonly than males, especially following menopause.
The underlying mechanism is an imbalance between bone resorption and bone formation, with resorption predominating. Advanced age is the most significant risk factor. Additional contributors include inadequate dietary calcium intake, particularly early in life, a sedentary lifestyle with lack of weight-bearing activity, and estrogen deficiency after menopause. Other important risk factors include long-term corticosteroid use, alcoholism, methotrexate therapy, tobacco use, low body weight, and familial predisposition. Pediatric patients are generally asymptomatic despite early onset of bone loss.
Osteoporosis is usually clinically silent until pathologic fractures occur. Fractures resulting from minimal trauma or recurrent fractures are hallmark features. The vertebral column is most commonly involved, with multiple compression fractures often leading to kyphosis and scoliosis. Hip fractures, including femoral neck and intertrochanteric fractures, are also frequent. A history of fractures after low-energy mechanisms or a family history of osteoporosis should raise suspicion. Physical examination findings typically relate to the acute fracture rather than the underlying disease itself.
Evaluation focuses on identifying fractures without significant mechanisms and assessing risk factors. A careful neurovascular examination distal to femoral or other extremity fractures is essential. In patients with vertebral fractures, rectal tone and postvoid residual should be assessed. Plain radiographs of suspected fractures may show osteopenia, though this is a late finding. Spine films may reveal old compression fractures. Computed tomography is recommended for vertebral fractures to assess for retropulsion and spinal canal compromise, which may not be evident on plain films.
Laboratory studies such as serum calcium, parathyroid hormone, and alkaline phosphatase can help differentiate osteoporosis from other metabolic bone disorders. Imaging with plain radiographs identifies fractures, but determining fracture age can be difficult. Bone scan or CT may help clarify fracture chronicity, particularly in the spine. Bone densitometry using dual-energy x-ray absorptiometry confirms the diagnosis, with a bone mineral density T-score of −2.5 or lower defining osteoporosis.
The differential diagnosis includes multiple myeloma or metastatic malignancy, osteogenesis imperfecta, hyperparathyroidism, and other demineralizing bone diseases. Management in the emergency setting prioritizes fracture care. Prehospital providers should minimize patient movement and report mechanism details suggestive of pathologic fracture. Initial treatment involves immobilization and standard fracture management, recognizing that healing may be delayed or incomplete. Orthotic back braces may be needed for vertebral fractures in consultation with orthopedics. Prevention remains more effective than acute treatment, and long-term therapy should be initiated or reinforced.
Pharmacologic therapy includes bisphosphonates such as alendronate or risedronate as first-line agents, with alternatives including zoledronic acid, raloxifene, denosumab, calcitonin, parathyroid hormone analogs, and, in selected cases, estrogen therapy. Adequate calcium and vitamin D supplementation are essential. Admission decisions follow standard orthopedic protocols, with particular attention to age, mobility, neurologic symptoms, and social factors. Compression fractures are often stable, but cervical fractures or those with neurologic deficits require admission and emergent specialty consultation.
Key points include recognizing recurrent or low-energy fractures as suggestive of osteoporosis, understanding that osteopenia on plain radiographs is a late but important clue, and initiating referral for definitive evaluation and treatment. Bisphosphonates remain first-line therapy for long-term management, and coordinated follow-up is critical to prevent future fractures.
- Published on
Emergency and Acute Medicine – Neonatal Jaundice
Neonatal jaundice results from an imbalance between bilirubin production and elimination. Newborns produce bilirubin at a higher rate than adults because of increased red blood cell mass and a shorter red blood cell lifespan. At the same time, especially in preterm infants, hepatic conjugation and biliary excretion of bilirubin are immature. Increased enterohepatic circulation and reduced bilirubin binding to albumin further contribute to elevated bilirubin levels. In most newborns, this process leads to physiologic jaundice, which is benign and self-limited.
In physiologic jaundice, bilirubin levels typically rise from approximately 1.5 mg/dL in cord blood to a mean peak of about 6.5 mg/dL by the third day of life, then gradually decline to less than 1.5 mg/dL by 10–12 days of age. However, when bilirubin levels rise excessively or rapidly, they may overwhelm neuroprotective mechanisms. Unbound bilirubin can cross the blood–brain barrier and deposit in the basal ganglia, hippocampus, brainstem nuclei, and cerebellum, leading to bilirubin-induced neurologic dysfunction (BIND). This spectrum ranges from mild neurologic dysfunction to acute bilirubin encephalopathy (ABE) in the first week of life, and to kernicterus, the chronic and often devastating form associated with permanent neurologic sequelae such as choreoathetoid cerebral palsy, gaze abnormalities, hearing loss, and dental dysplasia. Severe cases may result in coma, seizures, respiratory failure, and death.
The progression and severity of bilirubin neurotoxicity depend on multiple factors, including the rate and duration of bilirubin elevation, albumin-binding capacity, levels of unbound bilirubin, host susceptibility, and the presence of comorbidities. Risk factors for severe hyperbilirubinemia include jaundice in the first 24 hours of life, high predischarge total serum bilirubin (TSB) or transcutaneous bilirubin (TcB) levels, lower gestational age (35–38 weeks), exclusive breastfeeding with inadequate intake and excessive weight loss, hemolytic disease, a family history of neonatal jaundice, cephalohematoma or significant bruising, and East Asian ethnicity. Neurotoxicity risk is further increased by isoimmune hemolytic disease, G6PD deficiency, asphyxia, sepsis, acidosis, low albumin levels, and post-phototherapy bilirubin rebound.
Etiologies of neonatal jaundice are broadly divided into unconjugated and conjugated hyperbilirubinemia. Unconjugated causes include physiologic jaundice, breastfeeding failure jaundice due to inadequate milk intake in the first week of life, and breast milk jaundice, which typically begins after day 3–5 and may persist for several weeks. Hemolytic causes include ABO or Rh incompatibility, red cell enzyme deficiencies such as G6PD deficiency, and membrane disorders like hereditary spherocytosis. Other contributors include sepsis, birth trauma with increased heme load, polycythemia, infants of diabetic mothers, congenital hypothyroidism, and inherited defects of bilirubin conjugation such as Gilbert syndrome or Crigler–Najjar syndrome. Conjugated hyperbilirubinemia reflects impaired excretion and is always pathologic, with causes including neonatal hepatitis, biliary atresia, extrahepatic obstruction, shock liver, and neonatal hemosiderosis.
Clinically, affected infants may present with sleepiness, poor feeding, decreased urine output, or signs of dehydration. Early ABE is characterized by feeding difficulties, hypotonia, irritability, and lethargy. Intermediate stages include a high-pitched cry, fever, and increased tone with retrocollis and opisthotonos. Advanced ABE presents with severe hypertonia, seizures, coma, and abnormal movements. On examination, jaundice manifests as yellow discoloration of the skin and sclera, progressing in a cephalocaudal pattern as bilirubin levels rise. Visual assessment alone is unreliable, particularly in infants with darker skin tones. Neurologic abnormalities such as altered tone and the “setting sun” sign should raise concern for neurotoxicity.
Evaluation requires prompt measurement of total serum bilirubin in any infant with suspected or visible jaundice. The initial bilirubin level must be fractionated into unconjugated and conjugated components. TSB values must always be interpreted according to the infant’s age in hours, not days, and plotted on an age-specific nomogram to assess risk and guide treatment decisions. TcB measurements correlate well with TSB when available. Further evaluation is warranted when jaundice appears in the first 24 hours, persists beyond the first week, reaches phototherapy thresholds, involves elevated conjugated bilirubin, or is associated with signs of ABE. Additional laboratory studies may include serum albumin, electrolytes, renal function, complete blood count, reticulocyte count, blood type, direct Coombs test, and sepsis evaluation when indicated.
Management is time-sensitive, as outcomes are closely linked to the duration and severity of bilirubin exposure. Infants with signs of encephalopathy require immediate treatment. Phototherapy should be initiated when TSB exceeds threshold levels based on age in hours and risk stratification. Intensive phototherapy involves high irradiance delivered to as much of the infant’s surface area as possible, with eye protection in place, and should result in a bilirubin decline of more than 0.5 mg/dL per hour. Exchange transfusion is indicated for infants who meet age-specific thresholds, fail to respond to intensive phototherapy, or exhibit signs of ABE, and requires neonatal intensive care support. Intravenous immunoglobulin may be considered in isoimmune hemolytic disease when bilirubin levels approach exchange thresholds.
Supportive care includes ensuring adequate hydration, correcting dehydration with intravenous fluids when necessary, and optimizing feeding. Breastfeeding should generally continue, with increased feeding frequency and supplementation as needed. Temporary cessation of breastfeeding may be considered in refractory breast milk jaundice, with maternal milk expression encouraged to maintain lactation. Underlying conditions such as sepsis, hypothyroidism, or polycythemia must be identified and treated promptly.
Hospital admission is required for infants needing intensive phototherapy, exchange transfusion, or evaluation of significant anemia, infection, dehydration, or suspected obstructive liver disease. Stable term infants with uncomplicated hyperbilirubinemia below treatment thresholds may be managed with close outpatient follow-up or home phototherapy when appropriate. Clear communication with primary care providers and timely follow-up—often within 8–12 hours—is essential to prevent progression to severe hyperbilirubinemia.
A key principle in the emergency setting is that bilirubin levels must always be interpreted in the context of postnatal age in hours and individual risk factors. Early recognition, prompt initiation of phototherapy when indicated, and careful assessment of feeding and hydration are critical to preventing irreversible neurologic injury.
